Innovative Eyewear (LUCY) vs STAAR Surgical (STAA)
Head-to-head comparison of performance, valuation, growth, profitability and dividends. Prices delayed 15 minutes; data as of Nov 22, 2026.
Summary
STAAR Surgical is the larger company by market cap ($1.22 billion vs $6.1 million), about 198.7 times the size, while Innovative Eyewear is growing revenue faster (+62.6% vs -23.7%). STAAR Surgical converts more of its revenue into profit, with a net margin of -33.6% versus -285.2%.
Summary generated from market data by MetaCap's automated system. Methodology
Relative performance
Percent change in share price from the first common trading day shown; excludes dividends.
Head-to-head
| Metric | LUCY | STAA |
|---|---|---|
| Share price | $0.7025 | $24.22 |
| Market cap | $6.12M | $1.22B |
| 1-day change | -0.07% | -3.24% |
| YTD return | — | +4.89% |
| 1-year return | — | -13.50% |
| 5-year return | — | -75.08% |
| Forward P/E | — | 21.39 |
| EPS (TTM) | $-1.17 | $0.01 |
| Dividend yield | 0.00% | 0.00% |
| Annual dividend | $0.00 | $0.00 |
| Revenue (latest FY) | $2.66M | $239.44M |
| Revenue growth (YoY) | +62.65% | -23.72% |
| Net income (latest FY) | $-7.59M | $-80.45M |
| Gross margin | 21.32% | 76.19% |
| Operating margin | — | -38.30% |
| Net margin | -285.20% | -33.60% |
| 52-week high | $2.00 | $35.87 |
| 52-week low | $0.65 | $15.59 |
| Distance from 52-week high | -64.88% | -32.48% |
| Analyst consensus | — | buy |
| Avg. price target upside | — | +17.92% |
| Average volume | 3.52M | 835.89K |
| Shares outstanding | 8.71M | 50.20M |
| Employees | 13 | 921 |
| Sector | Health Care | Health Care |
| Industry | Ophthalmic Goods | Ophthalmic Goods |
Highlighted cells mark the higher value for growth, returns, margins and yield, and the lower value for P/E ratios. Highlighting is a mechanical comparison, not a recommendation.
Key differences
- STAAR Surgical is about 198.7 times larger than Innovative Eyewear by market value ($1.22B vs $6.12M).
- STAAR Surgical is more profitable, keeping -33.6 cents of every revenue dollar as net income versus -285.2 cents for Innovative Eyewear.
- Innovative Eyewear grew revenue faster in its latest fiscal year (+62.65% vs -23.72%).
About Innovative Eyewear
LUCY stock →Lucyd, Inc develops and sells smart eyewear in North America. It offers smart eyewear products to enable wearer to listen to music, take and make calls, and use voice assistants and ChatGPT to perform smartphone tasks hands-free, as well as prescription eyeglasses, ready-to-wear sunglasses, safety glasses, and sport glasses under the Lucyd Lyte, Lucyd Armor, Nautica, Eddie Bauer, and Reebok brand names.
Health Care · Ophthalmic Goods · 13 employees
About STAAR Surgical
STAA stock →STAAR Surgical Company, together with its subsidiaries, designs, develops, manufactures, and sells phakic implantable lenses for the eye and accessory delivery systems to deliver the lenses into the eye. The company offers implantable collamer lens product family (ICLs) comprising EVO ICL, EVO+ ICL, EVO Visian ICL, and EVO Viva ICL for use in refractive surgery for the treatment of visual disorders, such as myopia, hyperopia, astigmatism, and presbyopia.
Health Care · Ophthalmic Goods · 921 employees
LUCY vs STAA FAQ
Which is bigger, Innovative Eyewear or STAAR Surgical?
STAAR Surgical (STAA) is larger, with a market capitalization of $1.22B compared with $6.12M for Innovative Eyewear (LUCY).
Are Innovative Eyewear and STAAR Surgical in the same industry?
Yes. Both are classified in the Ophthalmic Goods industry within the Health Care sector.